Minocycline Enhances MPTP Toxicity to Dopaminergic Neurons

Chronic Parkinsonism in Humans Due to a Product of Meperidine-Analog Synthesis

Langston, J. W., Ballard, P., Tetrud, J. W., & Irwin, I. (1983) · Science · doi:10.1126/science.6823561 · Cited by 4,914 · see citing works

Inhibition of NADH-linked oxidation in brain mitochondria by 1-methyl-4-phenyl-pyridine, a metabolite of the neurotoxin, 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine

Nicklas, W. J., Vyas, I. L., & Heikkila, R. E. (1985) · Life Sciences · doi:10.1016/0024-3205(85)90146-8 · Cited by 1,266 · see citing works

Parkinsonism-inducing neurotoxin, N-methyl-4-phenyl-1,2,3,6 -tetrahydropyridine: uptake of the metabolite N-methyl-4-phenylpyridine by dopamine neurons explains selective toxicity.

Javitch, J. A., D’Amato, R. J., Strittmatter, S. M., & Snyder, S. H. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.7.2173 · Cited by 1,264 · see citing works

Blockade of Microglial Activation Is Neuroprotective in the 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine Mouse Model of Parkinson Disease

Wu, D. C., Jackson-Lewis, V., Vila, M., Tieu, K., Teismann, P., Vadseth, C., Choi, D.-K., Ischiropoulos, H., & Przedborski, S. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-05-01763.2002 · Cited by 1,183 · see citing works

Metabolism of the neurotoxic tertiary amine, MPTP, by brain monoamine oxidase

Chiba, K., Trevor, A. J., & Castagnoli, N. (1984) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(84)91293-2 · Cited by 1,098 · see citing works

Minocycline inhibits cytochrome c release and delays progression of amyotrophic lateral sclerosis in mice

Zhu, S., Stavrovskaya, I. G., Drozda, M., Kim, B. Y. S., Ona, V. O., Li, M., Sarang, S. S., Liu, A. S., Hartley, D. M., Wu, D. C., et al. (2002) · Nature · doi:10.1038/417074a · Cited by 1,071 · see citing works

Minocycline inhibits caspase-1 and caspase-3 expression and delays mortality in a transgenic mouse model of Huntington disease

Chen, M., Ona, V. O., Li, M., Ferrante, R. J., Fink, K., Zhu, S., Bian, J., Guo, L., Farrell, L. A., Hersch, S. M., et al. (2000) · Nature Medicine · doi:10.1038/77528 · Cited by 1,056 · see citing works

Inducible nitric oxide synthase stimulates dopaminergic neurodegeneration in the MPTP model of Parkinson disease

Liberatore, G. T., Jackson-Lewis, V., Vukosavic, S., Mandir, A. S., Vila, M., McAuliffe, W. G., Dawson, V. L., Dawson, T. M., & Przedborski, S. (1999) · Nature Medicine · doi:10.1038/70978 · Cited by 1,046 · cited 2× · see citing works

A tetracycline derivative, minocycline, reduces inflammation and protects against focal cerebral ischemia with a wide therapeutic window

Yrjänheikki, J., Kauppinen, T. M., Keinänen, R., Goldsteins, G., Chan, P. H., & Koıstınaho, J. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.23.13496 · Cited by 1,040 · see citing works

Dopaminergic Neurotoxicity of 1-Methyl-4-Phenyl-1,2,5,6-Tetrahydropyridine in Mice

Heikkila, R. E., Hess, A., & Duvoisin, R. C. (1984) · Science · doi:10.1126/science.6610213 · Cited by 1,010 · see citing works

Tetracyclines inhibit microglial activation and are neuroprotective in global brain ischemia

Yrjänheikki, J., Keinänen, R., Pellikka, M., Hökfelt, T., & Koistinaho, J. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.26.15769 · Cited by 1,006 · see citing works

Minocycline, a tetracycline derivative, is neuroprotective against excitotoxicity by inhibiting activation and proliferation of microglia

Tikka, T., Fiebich, B. L., Goldsteins, G., Keinänen, R., & Koistinaho, J. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-08-02580.2001 · Cited by 958 · see citing works

Minocycline Prevents Nigrostriatal Dopaminergic Neurodegeneration in the MPTP Model of Parkinson’s Disease

Du, Y., Ma, Z., Lin, S., Dodel, R. C., Gao, F., Bales, K. R., Triarhou, L. C., Chernet, E., Perry, K. W., Nelson, D. L. G., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.251341998 · Cited by 789 · see citing works

Dopamine-dependent neurotoxicity of α-synuclein: A mechanism for selective neurodegeneration in Parkinson disease

Xu, J., Kao, S., Lee, F. J. S., Song, W., Jin, L., & Yankner, B. A. (2002) · Nature Medicine · doi:10.1038/nm0602-600 · Cited by 757 · see citing works

Vesicle Permeabilization by Protofibrillar α-Synuclein: Implications for the Pathogenesis and Treatment of Parkinson's Disease

Volles, M. J., Lee, S., Rochet, J., Shtilerman, M. D., Ding, T. T., Kessler, J. C., & Lansbury, P. T. (2001) · Biochemistry · doi:10.1021/bi0102398 · Cited by 682 · see citing works

Dopamine Oxidation Alters Mitochondrial Respiration and Induces Permeability Transition in Brain Mitochondria

Berman, S. B., & Hastings, T. G. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0731127.x · Cited by 664 · see citing works

A cDNA that suppresses MPP+ toxicity encodes a vesicular amine transporter

Liu, Y. (1992) · Cell · doi:10.1016/0092-8674(92)90425-c · Cited by 589 · see citing works

Epidermal immunization by a needle-free powder delivery technology: Immunogenicity of influenza vaccine and protection in mice

Chen, D., Endres, R. L., Erickson, C. A., Weis, K. F., McGregor, M. W., Kawaoka, Y., & Payne, L. G. (2000) · Nature Medicine · doi:10.1038/80538 · Cited by 547 · see citing works

A consideration of neural counting methods

Coggeshall, R. E. (1992) · Trends in Neurosciences · doi:10.1016/0166-2236(92)90339-a · Cited by 540 · see citing works

Changes in cytokines and neurotrophins in Parkinson’s disease

Nagatsu, T., Mogi, M., Ichinose, H., & Togari, A. (2000) · Springer eBooks · doi:10.1007/978-3-7091-6301-6_19 · Cited by 507 · see citing works

Microglia in degenerative neurological disease

McGeer, P. L., Kawamata, T., Walker, D. G., Akiyama, H., Tooyama, I., & McGeer, E. G. (1993) · Glia · doi:10.1002/glia.440070114 · Cited by 500 · see citing works

A novel mechanism of action of tetracyclines: Effects on nitric oxide synthases

Amin, A. R., Attur, M. G., Thakker, G. D., Patel, P. D., Vyas, P., Patel, R. N., Patel, I. R., & Abramson, S. B. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.24.14014 · Cited by 474 · see citing works

VMAT2 knockout mice: Heterozygotes display reduced amphetamine-conditioned reward, enhanced amphetamine locomotion, and enhanced MPTP toxicity

Takahashi, N., Miner, L. L., Sora, I., Ujike, H., Revay, R. S., Kostić, V., Jackson-Lewis, V. R., Przedborski, S., & Uhl, G. R. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.18.9938 · Cited by 429 · see citing works

The Inflammatory Reaction Following 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine Intoxication in Mouse

Kurkowska‐Jastrzębska, I., Wrońska, A., Kohutnicka, M., Członkowski, A., & Członkowska, A. (1999) · Experimental Neurology · doi:10.1006/exnr.1998.6993 · Cited by 379 · see citing works

Creatine and Cyclocreatine Attenuate MPTP Neurotoxicity

Matthews, R. T., Ferrante, R. J., Klivènyi, P., Yang, L., Klein, A., Mueller, G., Kaddurah-Daouk, R. F., & Beal, M. F. (1999) · Experimental Neurology · doi:10.1006/exnr.1999.7049 · Cited by 374 · see citing works

Minocycline inhibits microglial activation and protects nigral cells after 6-hydroxydopamine injection into mouse striatum

He, Y., Appel, S. H., & Le, W. (2001) · Brain Research · doi:10.1016/s0006-8993(01)02681-6 · Cited by 350 · see citing works

Midbrain dopaminergic neurons (nuclei A8, A9, and A10): Three‐dimensional reconstruction in the rat

German, D. C., & Manaye, K. F. (1993) · The Journal of Comparative Neurology · doi:10.1002/cne.903310302 · Cited by 255 · see citing works

1-Methyl-4-phenyl-1,2,3,6-tetrahydropyride Neurotoxicity Is Attenuated in Mice Overexpressing Bcl-2

Yang, L., Matthews, R. T., Schulz, J. B., Klockgether, T., Liao, A., Martinou, J., Penney, J. B., Hyman, B. T., & Beal, M. F. (1998) · Journal of Neuroscience · doi:10.1523/jneurosci.18-20-08145.1998 · Cited by 199 · see citing works

Increased MPTP Neurotoxicity in Vesicular Monoamine Transporter 2 Heterozygote Knockout Mice

Gainetdinov, R. R., Fumagalli, F., Wang, Y., Jones, S. R., Levey, A. I., Miller, G. W., & Caron, M. G. (1998) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1998.70051973.x · Cited by 178 · see citing works

Selective dopaminergic vulnerability: 3,4-dihydroxyphenylacetaldehyde targets mitochondria

Kristal, B. S. (2001) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(01)00484-1 · Cited by 134 · see citing works

Inhibition of Brain Vesicular Monoamine Transporter (VMAT2) Enhances 1-Methyl-4-phenylpyridinium Neurotoxicity In Vivo in Rat Striata

Staal, R. G. W., & Sonsalla, P. K. (2000) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)39240-7 · Cited by 98 · see citing works

Increased vulnerability of dopaminergic neurons in MPTP‐lesioned interleukin‐6 deficient mice

Bolin, L., Strycharska-Orczyk, I., Murray, R., Langston, J., & Monte, D. D. D. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.01131.x · Cited by 95 · see citing works

Role of TNF-α Receptors in Mice Intoxicated with the Parkinsonian Toxin MPTP

Rousselet, E., Callebert, J., Parain, K., Joubert, C., Hunot, S., Hartmann, A., Jacque, C., Pérez-Díaz, F., Cohen‐Salmon, C., Launay, J., et al. (2002) · Experimental Neurology · doi:10.1006/exnr.2002.7960 · Cited by 90 · see citing works

Stereology: the fast lane between neuroanatomy and brain function or still only a tightrope?

Gundersen, H. J. G. (1992) · Acta Neurologica Scandinavica · doi:10.1111/j.1600-0404.1992.tb05032.x · Cited by 81 · see citing works

Brain-derived neurotrophic factor prevents the loss of nigral neurons induced by excitotoxic striatal-pallidal lesions

Volpe, B. T., Wildmann, J., & Altar, C. A. (1998) · Neuroscience · doi:10.1016/s0306-4522(97)00424-7 · Cited by 70 · see citing works

Selective MPP+ uptake into synaptic dopamine vesicles: possible involvement in MPTP neurotoxicity

Zompo, M. D., Piccardi, M. P., Ruiu, S., Quartu, M., GESSA, G. L., & Vaccari, A. (1993) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1993.tb13584.x · Cited by 69 · see citing works

In Vitro Studies of Striatal Vesicles Containing the Vesicular Monoamine Transporter (VMAT2): Rat versus Mouse Differences in Sequestration of 1-Methyl-4-phenylpyridinium

Staal, R. G. W., Hogan, K. A., Liang, C., German, D. C., & Sonsalla, P. K. (2000) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)39239-0 · Cited by 65 · see citing works

Histological and temporal characteristics of nigral transneuronal degeneration after striatal injury

DeGiorgio, L. A., Dibinis, C., Milner, T. A., Saji, M., & Volpe, B. T. (1998) · Brain Research · doi:10.1016/s0006-8993(98)00247-9 · Cited by 42 · see citing works

Pharmacological inactivation of the vesicular monoamine transporter can enhance 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurodegeneration of midbrain dopaminergic neurons, but not locus coeruleus noradrenergic neurons

German, D. C., Liang, C., Manaye, K. F., Lane, K. B., & Sonsalla, P. K. (2000) · Neuroscience · doi:10.1016/s0306-4522(00)00385-7 · Cited by 41 · see citing works

Characteristics of Dopaminergic Neurotoxicity Produced by MPTP and Methamphetaminea

Sonsalla, P. K., Giovanni, A., Sieber, B.-A., Donne, K. T. D., & Manzino, L. (1992) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1992.tb24542.x · Cited by 38 · see citing works

Differential spatial and temporal gene expression in response to axotomy and deafferentation following transection of the medial forebrain bundle

Weiser, M. J., Baker, H. A., Wessel, T., & Joh, T. (1993) · Journal of Neuroscience · doi:10.1523/jneurosci.13-08-03472.1993 · Cited by 36 · see citing works

Damage to dopaminergic nerve terminals in mice by combined treatment of intrastriatal malonate with systemic methamphetamine or MPTP

Albers, D. S., Zeevalk, G. D., & Sonsalla, P. K. (1996) · Brain Research · doi:10.1016/0006-8993(96)00135-7 · Cited by 35 · see citing works

Delayed histopathological neuronal damage in the substantia nigra compacta (nucleus A9) after transient forebrain ischaemia

Volpe, B. T., Blau, A. D., Wessel, T. C., & Saji, M. (1995) · Neurobiology of Disease · doi:10.1006/nbdi.1995.0012 · Cited by 28 · see citing works

Cytokines and chemokines: At the crossroads of cell signalling and inflammatory disease

Turner, M. D., Nedjai, B., Hurst, T. P., & Pennington, D. J. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2014.05.014 · Cited by 2,186 · see citing works

Neuroinflammation in Parkinson’s disease: A target for neuroprotection?

Hirsch, E. C., & Hunot, S. (2009) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70062-6 · Cited by 1,984 · see citing works

Oxidative stress in neurodegeneration: Cause or consequence?

Andersen, J. K. (2004) · Nature Medicine · doi:10.1038/nrn1434 · Cited by 1,869 · see citing works

Neuroinflammation in Parkinson's disease: Its role in neuronal death and implications for therapeutic intervention

Tansey, M. G., & Goldberg, M. S. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.11.004 · Cited by 1,045 · see citing works

Minocycline: Far beyond an Antibiotic

Garrido‐Mesa, N., Zarzuelo, A., & Gálvez, J. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12139 · Cited by 935 · see citing works

Efficacy of minocycline in patients with amyotrophic lateral sclerosis: a phase III randomised trial

Gordon, P. H., Moore, D. H., Miller, R. G., Florence, J. M., Verheijde, J. L., Doorish, C., Hilton, J. F., Spitalny, G. M., MacArthur, R. B., Mitsumoto, H., et al. (2007) · The Lancet Neurology · doi:10.1016/s1474-4422(07)70270-3 · Cited by 649 · see citing works

MPTP Mouse Models of Parkinson’s Disease: An Update

Meredith, G. E., & Rademacher, D. J. (2011) · Journal of Parkinson's Disease · doi:10.3233/jpd-2011-11023 · Cited by 471 · see citing works

The Promise of Minocycline in Neurology

Yong, V. W., Wells, J., Giuliani, F., Casha, S., Power, C., & Metz, L. M. (2004) · The Lancet Neurology · doi:10.1016/s1474-4422(04)00937-8 · Cited by 518 · see citing works

A randomized, double-blind, futility clinical trial of creatine and minocycline in early Parkinson disease

The NINDS NET-PD Investigators (2006) · Neurology · doi:10.1212/01.wnl.0000201252.57661.e1 · Cited by 453 · see citing works

Involvement of Interferon-γ in Microglial-Mediated Loss of Dopaminergic Neurons

Mount, M. P., Lira, A., Grimes, D., Smith, P. D., Faucher, S., Slack, R. S., Anisman, H., Hayley, S. P., & Park, D. S. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.5321-06.2007 · Cited by 316 · see citing works

Neuroinflammation and oxidative stress: Co-conspirators in the pathology of Parkinson’s disease

Taylor, J. M., Main, B. S., & Crack, P. J. (2013) · Neurochemistry International · doi:10.1016/j.neuint.2012.12.016 · Cited by 303 · see citing works

Contributions of central and systemic inflammation to the pathophysiology of Parkinson's disease

Collins, L. M., Toulouse, A., Connor, T. J., & Nolan, Y. M. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.01.028 · Cited by 275 · see citing works

The influence of microglia on the pathogenesis of Parkinson's disease

Long-Smith, C. M., Sullivan, A. M., & Nolan, Y. M. (2009) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2009.08.001 · Cited by 296 · see citing works

Prospects for Minocycline Neuroprotection

Plane, J. M., Shen, Y., Pleasure, D., & Deng, W. (2010) · Archives of Neurology · doi:10.1001/archneurol.2010.191 · Cited by 276 · see citing works

Minocycline attenuates microglial activation but fails to mitigate striatal dopaminergic neurotoxicity: role of tumor necrosis factor‐α

Sriram, K., Miller, D. B., & O'Callaghan, J. P. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03566.x · Cited by 242 · see citing works

Transient neuroprotection by minocycline following traumatic brain injury is associated with attenuated microglial activation but no changes in cell apoptosis or neutrophil infiltration

Bye, N., Habgood, M. D., Callaway, J. K., Malakooti, N., Potter, A., Kossmann, T., & Morganti-Kossmann, M. C. (2006) · Experimental Neurology · doi:10.1016/j.expneurol.2006.10.013 · Cited by 239 · see citing works

Neuroimmunological Processes in Parkinson’s Disease and their Relation to α-Synuclein: Microglia as the Referee between Neuronal Processes and Peripheral Immunity

Sánchez-Guajardo, V., Barnum, C. J., Tansey, M. G., & Romero‐Ramos, M. (2013) · ASN NEURO · doi:10.1042/an20120066 · Cited by 237 · see citing works

Gut microbiota: Implications in Parkinson's disease

Parashar, A., & Malairaman, U. (2017) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2017.02.002 · Cited by 231 · see citing works

Deficiency of TNF receptors suppresses microglial activation and alters the susceptibility of brain regions to MPTP‐induced neurotoxicity: role of TNF‐α 1

Sriram, K., Matheson, J. M., Benkovic, S. A., Miller, D. B., Luster, M. I., & O'Callaghan, J. P. (2006) · The FASEB Journal · doi:10.1096/fj.05-5106com · Cited by 224 · see citing works

Experimental therapeutics in transgenic mouse models of Huntington's disease

Beal, M. F., & Ferrante, R. J. (2004) · Nature reviews. Neuroscience · doi:10.1038/nrn1386 · Cited by 224 · see citing works

Neuroprotection by tetracyclines

Domercq, M., & Matute, C. (2004) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2004.10.001 · Cited by 205 · see citing works

Critical data‐based re‐evaluation of minocycline as a putative specific microglia inhibitor

Möller, T., Bard, F., Bhattacharya, A., Biber, K. P. H., Campbell, B., Dale, E., Eder, C., Gan, L., Garden, G. A., Hughes, Z. A., et al. (2016) · Glia · doi:10.1002/glia.23007 · Cited by 192 · see citing works

Deleterious Effects of Minocycline in Animal Models of Parkinson’s Disease and Huntington’s Disease

Diguet, E., Fernagut, P., Wei, X., Du, Y., Rouland, R., Gross, C., Bezard, E., & Tison, F. (2004) · European Journal of Neuroscience · doi:10.1111/j.0953-816x.2004.03372.x · Cited by 189 · see citing works

Minocycline worsens hypoxic-ischemic brain injury in a neonatal mouse model

Tsuji, M., Wilson, M. A., Lange, M. S., & Johnston, M. V. (2004) · Experimental Neurology · doi:10.1016/j.expneurol.2004.01.011 · Cited by 181 · see citing works

Minocycline exerts inhibitory effects on multiple mitogen‐activated protein kinases and IκBα degradation in a stimulus‐specific manner in microglia

Nikodémová, M., Duncan, I. D., & Watters, J. J. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03520.x · Cited by 176 · see citing works

A Pilot Clinical Trial of Creatine and Minocycline in Early Parkinson Disease

Ninds Net-Pd Investigators (2008) · Clinical Neuropharmacology · doi:10.1097/wnf.0b013e3181342f32 · Cited by 174 · see citing works

Mitochondria Targeted Peptides Protect Against 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine Neurotoxicity

Yang, L., Zhao, K., Calingasan, N. Y., Luo, G., Szeto, H. H., & Beal, M. F. (2009) · Antioxidants and Redox Signaling · doi:10.1089/ars.2009.2445 · Cited by 169 · see citing works

Neural and Immune Mechanisms in the Pathogenesis of Parkinson’s Disease

Blandini, F. (2013) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-013-9435-y · Cited by 164 · see citing works

Clinical Potential of Minocycline for Neurodegenerative Disorders

BLUM, D., CHTARTO, A., TENENBAUM, L., BROTCHI, J., & LEVIVIER, M. (2004) · Neurobiology of Disease · doi:10.1016/j.nbd.2004.07.012 · Cited by 157 · see citing works

Evaluation of animal models of Parkinson's disease for neuroprotective strategies

Emborg, M. E. (2004) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2004.08.004 · Cited by 156 · see citing works

Neuroprotective effect of nicotine on dopaminergic neurons by anti‐inflammatory action

Park, H.-J., Lee, P. H., Ahn, Y. W., Choi, Y. J., Lee, G., Lee, D., Chung, E. S., & Jin, B. K. (2007) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2007.05636.x · Cited by 153 · see citing works

Neuroprotective effects of compounds with antioxidant and anti-inflammatory properties in a Drosophila model of Parkinson's disease

Faust, K., Gehrke, S., Yang, Y., Yang, L., Beal, M. F., & Lu, B. (2009) · BMC Neuroscience · doi:10.1186/1471-2202-10-109 · Cited by 151 · see citing works

Therapeutic targets and limits of minocycline neuroprotection in experimental ischemic stroke

Matsukawa, N., Yasuhara, T., Hara, K., Xu, L., Maki, M., Yu, G., Kaneko, Y., Ojika, K., Hess, D. C., & Borlongan, C. V. (2009) · BMC Neuroscience · doi:10.1186/1471-2202-10-126 · Cited by 146 · see citing works

The Promise of Neuroprotective Agents in Parkinson?s Disease

Seidl, S. E., & Potashkin, J. A. (2011) · Frontiers in Neurology · doi:10.3389/fneur.2011.00068 · Cited by 141 · see citing works

Glial degeneration and reactive gliosis in alpha-synucleinopathies: the emerging concept of primary gliodegeneration

Croisier, E., & Graeber, M. B. (2006) · Acta Neuropathologica · doi:10.1007/s00401-006-0119-z · Cited by 130 · see citing works

Neuroinflammation and Neuroimmune Dysregulation after Acute Hypoxic-Ischemic Injury of Developing Brain

Bhalala, U. S., Koehler, R. C., & Kannan, S. (2015) · Frontiers in Pediatrics · doi:10.3389/fped.2014.00144 · Cited by 128 · see citing works

Tanshinone I selectively suppresses pro-inflammatory genes expression in activated microglia and prevents nigrostriatal dopaminergic neurodegeneration in a mouse model of Parkinson׳s disease

Wang, S., Jing, H., Yang, H., Liu, Z., Guo, H. W., Chai, L., & Hu, L. (2015) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2015.01.042 · Cited by 126 · see citing works

The Potential of Minocycline for Neuroprotection in Human Neurologic Disease

Zemke, D., & Majid, A. (2004) · Clinical Neuropharmacology · doi:10.1097/01.wnf.0000150867.98887.3e · Cited by 125 · see citing works

Doxycycline restrains glia and confers neuroprotection in a 6‐OHDA Parkinson model

Lazzarini, M., Martin, S., Mitkovski, M., Raisman‐Vozari, R., Stühmer, W., & Bel, E. D. (2013) · Glia · doi:10.1002/glia.22496 · Cited by 119 · see citing works

Updates on immunity and inflammation in Parkinson disease pathology

Joshi, N., & Singh, S. (2017) · Journal of Neuroscience Research · doi:10.1002/jnr.24185 · Cited by 118 · see citing works

Optimal delivery of minocycline to the brain: implication for human studies of acute neuroprotection

Fagan, S. C., Edwards, D. J., Borlongan, C. V., Xu, L., Arora, A., Feuerstein, G., & Hess, D. C. (2004) · Experimental Neurology · doi:10.1016/j.expneurol.2003.12.006 · Cited by 117 · see citing works

Neuroprotectant minocycline depresses glutamatergic neurotransmission and Ca2+ signalling in hippocampal neurons

Gonzalez, J., Egea, J., Godino, M. D. C., Fernández-Gómez, F.-J., Sánchez‐Prieto, J., Gandı́a, L., Garcı́a, A. G., Jordán, J., & Hernández-Guijo, J. M. (2007) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2007.05873.x · Cited by 111 · see citing works

PET Imaging of the Peripheral Benzodiazepine Receptor: Monitoring Disease Progression and Therapy Response in Neurodegenerative Disorders

Doorduin, J., de Vries, E. F. J., Dierckx, R. A. J. O., & Klein, H. (2008) · Current Pharmaceutical Design · doi:10.2174/138161208786549443 · Cited by 107 · see citing works

Tetracycline repurposing in neurodegeneration: focus on Parkinson’s disease

Bortolanza, M., Nascimento, G. C., Socías, S. B., Ploper, D., Chehín, R. N., Raisman‐Vozari, R., & Bel, E. A. D. (2018) · Journal of Neural Transmission · doi:10.1007/s00702-018-1913-1 · Cited by 105 · see citing works

Activated microglia targeting dendrimer–minocycline conjugate as therapeutics for neuroinflammation.

Sharma, R., Kim, S.-Y., Sharma, A., Zhang, Z., Kambhampati, S. P., Kannan, S., & Kannan, R. M. (2017) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.7b00569 · Cited by 100 · see citing works

Modulation of microglial pro-inflammatory and neurotoxic activity for the treatment of Parkinson’s disease

Liu, B. (2006) · The AAPS Journal · doi:10.1208/aapsj080369 · Cited by 100 · see citing works

Rise and fall of minocycline in neuroprotection: need to promote publication of negative results

Diguet, E., Gross, C. E., Tison, F., & Bézard, E. (2004) · Experimental Neurology · doi:10.1016/j.expneurol.2004.05.016 · Cited by 97 · see citing works

Minocycline in neurodegenerative and psychiatric diseases: An update

Romero‐Miguel, D., Lamanna‐Rama, N., Casquero‐Veiga, M., Gómez‐Rangel, V., Desco, M., & Soto‐Montenegro, M. L. (2020) · European Journal of Neurology · doi:10.1111/ene.14642 · Cited by 95 · see citing works

A re-assessment of minocycline as a neuroprotective agent in a rat spinal cord contusion model

Pinzón, A., Marcillo, A. E., Quintana, A., Stamler, S., Bunge, M. B., Bramlett, H. M., & Dietrich, W. D. (2008) · Brain Research · doi:10.1016/j.brainres.2008.09.047 · Cited by 95 · see citing works

The Therapeutic Role of Minocycline in Parkinson’s Disease

Cankaya, S., Cankaya, B., Kilic, U., Kilic, E., & Yulug, B. (2019) · Drugs in Context · doi:10.7573/dic.212553 · Cited by 93 · see citing works

Modeling neuroinflammatory pathogenesis of Parkinson’s disease

Barnum, C. J., & Tansey, M. G. (2010) · Progress in brain research · doi:10.1016/s0079-6123(10)84006-3 · Cited by 91 · see citing works

The Interplay between Gut Microbiota and Parkinson’s Disease: Implications on Diagnosis and Treatment

Varesi, A., Campagnoli, L. I. M., Fahmideh, F., Pierella, E., Romeo, M., Ricevuti, G., Nicoletta, M., Chirumbolo, S., & Pascale, A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232012289 · Cited by 88 · see citing works

Role of microglia in a mouse model of paediatric traumatic brain injury

Chhor, V., Moretti, R., Charpentier, T. L., Sigaut, S., Lebon, S., Schwendimann, L., Oré, M.-V., Zuiani, C., Milan, V., Josserand, J., et al. (2016) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2016.11.001 · Cited by 87 · see citing works

Pathogenesis of α-Synuclein in Parkinson’s Disease: From a Neuron-Glia Crosstalk Perspective

Yi, S., Wang, L.-F., Wang, H., Ho, M., & Zhang, S.-P. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232314753 · Cited by 66 · see citing works

Neuroprotective strategies for Parkinson's disease: conceptual limits of animal models and clinical trials

Meissner, W. G., Hill, M. P., Tison, F., Gross, C. E., & Bézard, E. (2004) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2004.03.003 · Cited by 87 · see citing works

Mitochondrial Inhibition and Oxidative Stress: Reciprocating Players in Neurodegeneration

Zeevalk, G. D., Bernard, L. P., Song, C., Gluck, M. J., & Ehrhart, J. (2005) · Antioxidants and Redox Signaling · doi:10.1089/ars.2005.7.1117 · Cited by 87 · see citing works

Interrupting apoptosis in neurodegenerative disease: potential for effective therapy?

Waldmeier, P. C., & Tatton, W. G. (2004) · Drug Discovery Today · doi:10.1016/s1359-6446(03)03000-9 · Cited by 85 · see citing works

Targeting reactive oxygen species, reactive nitrogen species and inflammation in MPTP neurotoxicity and Parkinson’s disease

Yokoyama, H., Kuroiwa, H., Yano, R., & Araki, T. (2008) · Neurological Sciences · doi:10.1007/s10072-008-0986-2 · Cited by 85 · see citing works

Genetic findings in Parkinson’s disease and translation into treatment: a leading role for mitochondria?

Bogaerts, V., Theuns, J., & Broeckhoven, C. V. (2007) · Genes Brain & Behavior · doi:10.1111/j.1601-183x.2007.00342.x · Cited by 86 · see citing works

Strategies to Promote Neural Repair and Regeneration After Spinal Cord Injury

Kwon, B. K., Fisher, C. G., Dvorak, M. F., & Tetzlaff, W. (2005) · Spine · doi:10.1097/01.brs.0000175186.17923.87 · Cited by 77 · see citing works

Alternative microglial activation is associated with cessation of progressive dopamine neuron loss in mice systemically administered lipopolysaccharide

Beier, E. E., Neal, M. P., Alam, G., Edler, M. K., Wu, L., & Richardson, J. R. (2017) · Neurobiology of Disease · doi:10.1016/j.nbd.2017.08.009 · Cited by 76 · see citing works

Peripheral Immunity, Immunoaging and Neuroinflammation in Parkinson’s Disease

Kuštrimović, N. Z., Marino, F., & Cosentino, M. (2018) · Current Medicinal Chemistry · doi:10.2174/0929867325666181009161048 · Cited by 74 · see citing works

Lack of neuroprotective effects of simvastatin and minocycline in a model of cervical spinal cord injury

Lee, J. H. T., Tigchelaar, S., Liu, J., Stammers, A. T., Streijger, F., Tetzlaff, W., & Kwon, B. K. (2010) · Experimental Neurology · doi:10.1016/j.expneurol.2010.06.018 · Cited by 73 · see citing works

Comprehensive Behavioral Testing in the R6/2 Mouse Model of Huntington's Disease Shows No Benefit from CoQ10 or Minocycline

Menalled, L., Patry, M., Ragland, N., Lowden, P. A. S., Goodman, J., Minnich, J., Zahasky, B., Park, L., Leeds, J. M., Howland, D., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0009793 · Cited by 70 · see citing works

Neuroprotective and Neuro-Restorative Effects of Minocycline and Rasagiline in a Zebrafish 6-Hydroxydopamine Model of Parkinson’s Disease

Cronin, A., & Grealy, M. (2017) · Neuroscience · doi:10.1016/j.neuroscience.2017.10.018 · Cited by 68 · see citing works

Disease modification in Parkinson's disease

Schapira, A. H. V. (2004) · The Lancet Neurology · doi:10.1016/s1474-4422(04)00769-0 · Cited by 67 · see citing works

Interleukin-18 null mice show diminished microglial activation and reduced dopaminergic neuron loss following acute 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine treatment

Sugama, S., Wirz, S., Barr, A. M., Conti, B., Bartfai, T., & Shibasaki, T. (2004) · Neuroscience · doi:10.1016/j.neuroscience.2004.07.020 · Cited by 63 · see citing works

Involvement of mitochondrial potential and calcium buffering capacity in minocycline cytoprotective actions

Fernández-Gómez, F.-J., Galindo, M. F., Gómez-Lázaro, M., González-García, C., Ceña, V., Aguirre, N., & Jordán, J. (2005) · Neuroscience · doi:10.1016/j.neuroscience.2005.03.019 · Cited by 59 · see citing works

Remote Neurodegeneration: Multiple Actors for One Play

Viscomi, M. T., & Molinari, M. (2014) · Molecular Neurobiology · doi:10.1007/s12035-013-8629-x · Cited by 57 · see citing works

The matrix metalloproteinase inhibitor IPR-179 has antiseizure and antiepileptogenic effects

Broekaart, D. W. M., Bertran, A., Jia, S., Korotkov, A., Senkov, O., Bongaarts, A., Mills, J. D., Anink, J. J., Seco, J., Baayen, J. C., et al. (2020) · Journal of Clinical Investigation · doi:10.1172/jci138332 · Cited by 59 · see citing works

Neuroinflammation and Parkinson's disease.

Przedborski, S. (2007) · Handbook of Clinical Neurology · doi:10.1016/s0072-9752(07)83026-0 · Cited by 55 · see citing works

Minocycline and intracerebral hemorrhage: influence of injury severity and delay to treatment

Szymanska, A., Biernaskie, J. A., Laidley, D. T., Granter‐Button, S., & Corbett, D. (2005) · Experimental Neurology · doi:10.1016/j.expneurol.2005.09.011 · Cited by 56 · see citing works

An Investigation of the Neuroprotective Effects of Tetracycline Derivatives in Experimental Models of Retinal Cell Death

Baptiste, D. C., Hartwick, A. T. E., Jollimore, C. A. B., Baldridge, W. H., Seigel, G. M., & Kelly, M. E. M. (2004) · Molecular Pharmacology · doi:10.1124/mol.104.001081 · Cited by 55 · see citing works

Minocycline in phenotypic models of Huntington's disease

Bantubungi, K., Jacquard, C., Greco, A., Pintor, A., Chtarto, A., Taï, K., Galas, M., Tenenbaum, L., Déglon, N., Popoli, P., et al. (2004) · Neurobiology of Disease · doi:10.1016/j.nbd.2004.09.017 · Cited by 53 · see citing works

Role of reactive nitrogen and reactive oxygen species against MPTP neurotoxicity in mice

Yokoyama, H., Takagi, S., Watanabe, Y., Kato, H., & Araki, T. (2008) · Journal of Neural Transmission · doi:10.1007/s00702-008-0019-6 · Cited by 52 · see citing works

Targeting Neuro-Inflammatory Cytokines and Oxidative Stress by Minocycline Attenuates Quinolinic-Acid-Induced Huntington’s Disease-Like Symptoms in Rats

Kalonia, H., Mishra, J., & Kumar, A. (2012) · Neurotoxicity Research · doi:10.1007/s12640-012-9315-x · Cited by 51 · see citing works

Exacerbation of Dopaminergic Terminal Damage in a Mouse Model of Parkinson’s Disease by the G-Protein-Coupled Receptor Protease-Activated Receptor 1

Hamill, C. E., Caudle, W. M., Richardson, J. R., Yuan, H., Pennell, K. D., Greene, J. G., Miller, G. W., & Traynelis, S. F. (2007) · Molecular Pharmacology · doi:10.1124/mol.107.038158 · Cited by 51 · see citing works

Potential of Therapeutic Small Molecules in Apoptosis Regulation in the Treatment of Neurodegenerative Diseases: An Updated Review

Dailah, H. G. (2022) · Molecules · doi:10.3390/molecules27217207 · Cited by 50 · see citing works

Impact of minocycline on neurodegenerative diseases in rodents: a meta-analysis

Li, C., Yuan, K., & Schluesener, H. J. (2013) · Reviews in the Neurosciences · doi:10.1515/revneuro-2013-0040 · Cited by 50 · see citing works

Re-evaluation of mitochondrial permeability transition as a primary neuroprotective target of minocycline

Månsson, R., Hansson, M. J., Morota, S., Uchino, H., Ekdahl, C. T., & Elmér, E. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2006.09.008 · Cited by 46 · see citing works

Therapy with Minocycline Aggravates Experimental Rabies in Mice

Jackson, A. C., Scott, C. A., Owen, J., Weli, S. C., & Rossiter, J. P. (2007) · Journal of Virology · doi:10.1128/jvi.00323-07 · Cited by 44 · see citing works

The potential use of tetracyclines in neurodegenerative diseases and the role of nano-based drug delivery systems

Rahmani, M., Negro, S., & Barcia, E. (2022) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2022.106237 · Cited by 42 · see citing works

Paradoxical effects of minocycline in the developing mouse somatosensory cortex

Arnoux, I., Hoshiko, M., Diez, A. S., & Audinat, É. (2013) · Glia · doi:10.1002/glia.22612 · Cited by 39 · see citing works

Adaptive immune regulation of glial homeostasis as an immunization strategy for neurodegenerative diseases

Kosloski, L. M., Ha, D. M., Hutter-Saunders, J. A. L., Stone, D. K., Pichler, M. R., Reynolds, A. D., Gendelman, H. E., & Mosley, R. L. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.06834.x · Cited by 40 · see citing works

Protective effect of the radical scavenger edaravone against methamphetamine-induced dopaminergic neurotoxicity in mouse striatum

Kawasaki, T., Ishihara, K., Ago, Y., Nakamura, S., Itoh, S., Baba, A., & Matsuda, T. (2006) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2006.05.012 · Cited by 40 · see citing works

Therapeutic Strategies for Immune Transformation in Parkinson’s Disease

Saleh, M., Marković, M., Olson, K. E., Gendelman, H. E., & Mosley, R. L. (2022) · Journal of Parkinson s Disease · doi:10.3233/jpd-223278 · Cited by 40 · see citing works

Challenges of Repurposing Tetracyclines for the Treatment of Alzheimer’s and Parkinson’s Disease

Markulin, I., Matasin, M., Turk, V. E., & Salković-Petrisic, M. (2022) · Journal of Neural Transmission · doi:10.1007/s00702-021-02457-2 · Cited by 36 · see citing works

Prolonged Minocycline Treatment Impairs Motor Neuronal Survival and Glial Function in Organotypic Rat Spinal Cord Cultures

Pinkernelle, J., Fansa, H., Ebmeyer, U., & Keilhoff, G. (2013) · PLoS ONE · doi:10.1371/journal.pone.0073422 · Cited by 35 · see citing works

Multiple system atrophy: an update and emerging directions of biomarkers and clinical trials

Liu, M., Wang, Z., & Shang, H. (2024) · Journal of Neurology · doi:10.1007/s00415-024-12269-5 · Cited by 34 · see citing works

Microglial Ion Channels as Potential Targets for Neuroprotection in Parkinson’s Disease

Richardson, J. R., & Hossain, M. M. (2013) · Neural Plasticity · doi:10.1155/2013/587418 · Cited by 34 · see citing works

Minocycline fails to protect cerebellar granular cell cultures against malonate-induced cell death

Fernández-Gómez, F.-J., Gómez-Lázaro, M., Pastor, M. D., Calvo, S., Aguirre, N., Galindo, M. F., & Jordán, J. (2005) · Neurobiology of Disease · doi:10.1016/j.nbd.2005.03.019 · Cited by 32 · see citing works

Microglial Activation Promotes Cell Survival in Organotypic Cultures of Postnatal Mouse Retinal Explants

Ferrer‐Martín, R. M., Martín‐Oliva, D., Sierra, A., Carrasco, M., Martín‐Estebané, M., Calvente, R., Martín‐Guerrero, S. M., Marín‐Teva, J. L., Navascués, J., & Cuadros, M. Á. (2015) · PLoS ONE · doi:10.1371/journal.pone.0135238 · Cited by 32 · see citing works

Evaluation of putative inhibitors of mitochondrial permeability transition for brain disorders — Specificity vs. toxicity

Morota, S., Månsson, R., Hansson, M. J., Kasuya, K., Shimazu, M., Hasegawa, E., Yanagi, S., Omi, A., Uchino, H., & Elmér, E. (2009) · Experimental Neurology · doi:10.1016/j.expneurol.2009.03.036 · Cited by 30 · see citing works

Failure of neuronal protection by inhibition of glial activation in a rat model of striatonigral degeneration

Stefanova, N., Mitschnigg, M., Ghorayeb, I., Diguet, E., Geser, F., Tison, F., Poewe, W. H., & Wenning, G. K. (2004) · Journal of Neuroscience Research · doi:10.1002/jnr.20233 · Cited by 30 · see citing works

Urinary Tract Infection in Parkinson’s Disease

Hogg, E., Frank, S., Oft, J., Benway, B., Rashid, M. H., & Lahiri, S. (2022) · Journal of Parkinson s Disease · doi:10.3233/jpd-213103 · Cited by 28 · see citing works

Lack of evidence of direct mitochondrial involvement in the neuroprotective effect of minocycline

Cornet, S., Spinnewyn, B., Delaflotte, S., Charnet, C., Roubert, V., Favre, C., Hider, H., Chabrier, P. E., & Auguet, M. (2004) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2004.10.039 · Cited by 28 · see citing works

Minocycline treatment prevents cavitation in rats after a cortical devascularizing lesion

Hua, R., & Walz, W. (2006) · Brain Research · doi:10.1016/j.brainres.2006.03.072 · Cited by 27 · see citing works

Polymer brain-nanotherapeutics for multipronged inhibition of microglial α-synuclein aggregation, activation, and neurotoxicity

Bennett, N. K., Chmielowski, R., Abdelhamid, D. S., Faig, J. J., Francis, N. L., Baum, J., Pang, Z. P., Uhrich, K. E., & Moghe, P. V. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2016.10.001 · Cited by 27 · see citing works

Antineuroinflammation of Minocycline in Stroke

Chen, Y., Cai, Z., & Ke, Z. (2017) · The Neurologist · doi:10.1097/nrl.0000000000000136 · Cited by 27 · see citing works

Delivering Minocycline into Brain Endothelial Cells with Liposome-Based Technology

Xing, C., Levchenko, T. S., Guo, S., Stins, M. F., Torchilin, V. P., & Lo, E. H. (2012) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2012.48 · Cited by 26 · see citing works

Minocycline Prevents Nigrostriatal Dopaminergic Neurodegeneration in the MPTP Model of Parkinson’s Disease

Du, Y., Ma, Z., Lin, S., Dodel, R. C., Gao, F., Bales, K. R., Triarhou, L. C., Chernet, E., Perry, K. W., Nelson, D. L. G., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.251341998 · Cited by 789 · see citing works

Minocycline attenuates microglial activation but fails to mitigate striatal dopaminergic neurotoxicity: role of tumor necrosis factor‐α

Sriram, K., Miller, D. B., & O'Callaghan, J. P. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03566.x · Cited by 242 · see citing works

Blockade of Microglial Activation Is Neuroprotective in the 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine Mouse Model of Parkinson Disease

Wu, D. C., Jackson-Lewis, V., Vila, M., Tieu, K., Teismann, P., Vadseth, C., Choi, D.-K., Ischiropoulos, H., & Przedborski, S. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-05-01763.2002 · Cited by 1,183 · see citing works

Deleterious Effects of Minocycline in Animal Models of Parkinson’s Disease and Huntington’s Disease

Diguet, E., Fernagut, P., Wei, X., Du, Y., Rouland, R., Gross, C., Bezard, E., & Tison, F. (2004) · European Journal of Neuroscience · doi:10.1111/j.0953-816x.2004.03372.x · Cited by 189 · see citing works

Protective effects of minocycline on 3,4-methylenedioxymethamphetamine-induced neurotoxicity in serotonergic and dopaminergic neurons of mouse brain

Zhang, L., Shirayama, Y., Shimizu, E., Iyo, M., & Hashimoto, K. (2006) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2006.05.047 · Cited by 71 · see citing works